ArticleThe Journal of clinical investigation2018

JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling.

Yaping Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.